Composition
- Active ingredients
- CARBIDOPA 25MG; LEVODOPA 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- CARBIDOPA 25MG; LEVODOPA 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet, orally disintegratingThis page
- CARBIDOPA 10MG; LEVODOPA 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet, orally disintegratingANDA076699-001 · Discontinued
- CARBIDOPA 25MG; LEVODOPA 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet, orally disintegratingANDA076699-002 · Discontinued
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application ANDA076699.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Parcopa
- Active substance
- carbidopa
- Route
- Oral
- Dosage form
- Tablet, orally disintegrating
- Applicant
- Ucb Inc
- Status
- Discontinued
- FDA approval
- 27 Aug 2004
- Application
- ANDA076699-003
- RxCUI
- 2019